AIDS Research and Treatment / 2012 / Article / Tab 4

Clinical Study

Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa

Table 4

Mortality and survival in relation to oral HIV-KS.

MalesFemalesTotal

Mortality
 Number of patients who died11 (85%)10 (66%)21 (75%)
 Average time of death from oral HIV-KS diagnosis15 weeks12.1 weeks13.6 weeks
 Average CD4+ T cell count (cells/mm3) at oral HIV-KS diagnosis755464
Survival
 Number of patients who survived2 (15%)5 (33%)7 (25%)
 Average follow-up time76 weeks106 weeks91 weeks
 Average CD4+ T cell count (cells/mm3) at oral HIV-KS diagnosis258129166

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.